¼¼°èÀÇ ÄÝµå ¸±¸®ÇÁ ·Ñ¿Â ½ÃÀå
Cold Relief Roll-on
»óǰÄÚµå : 1758099
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 290 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,195,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,585,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÄÝµå ¸±¸®ÇÁ ·Ñ¿Â ½ÃÀåÀº 2030³â±îÁö 8¾ï 5,670¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 5¾ï 4,450¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ÄÝµå ¸±¸®ÇÁ ·Ñ¿Â ½ÃÀåÀº 2030³â¿¡´Â 8¾ï 5,670¸¸ ´Þ·¯¿¡ ´ÞÇϸç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 7.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ °¨±â/±âħ ¾ÖÇø®ÄÉÀ̼ÇÀº CAGR 9.6%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 4¾ï 4,770¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÄÚ ¾Ë·¹¸£±â ¾ÖÇø®ÄÉÀÌ¼Ç ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 5.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 4,830¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 12.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÄÝµå ¸±¸®ÇÁ ·Ñ¿Â ½ÃÀåÀº 2024³â¿¡ 1¾ï 4,830¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 1¾ï 8,600¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 12.6%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.8%¿Í 7.6%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÄÝµå ¸±¸®ÇÁ ·Ñ¿Â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ºü¸¥ È¿°ú¸¦ ¿øÇÏ´Â ¼ÒºñÀÚµé »çÀÌ¿¡¼­ °¨±â¾à ·Ñ¿ÂÀÌ Àα⸦ ²ø°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

°¨±â¾à ·Ñ¿ÂÀº ºñħ½ÀÀû Àû¿ë, ºñħ½ÀÀû Àû¿ë, ÄÚ¸·Èû, µÎÅë, ±ÙÀ°Åë°ú °°Àº °¨±â Áõ»óÀ» ÀÚ¿¬ÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ´Ù´Â ÀνÄÀ¸·Î ÀÎÇØ ¼ÒºñÀڵ鿡°Ô Å« È£ÀÀÀ» ¾ò°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿Ü¿ëÁ¦´Â ÀϹÝÀûÀ¸·Î À¯Ä®¸³Åõ½º, įÆÄ, ÆäÆÛ¹ÎÆ®, ¸àÅç°ú °°Àº ¿¡¼¾¼È ¿ÀÀÏÀ» ÇÔÀ¯Çϰí ÀÖÀ¸¸ç, ¾Æ·Î¸¶Å×¶óÇÇ¿Í ±¹¼Ò ÇǺΠÈí¼ö¸¦ ÅëÇØ Áõ»óÀ» ¿ÏÈ­ÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ·Ñ¿ÂÀº ¸Ô´Â ¾à°ú ´Þ¸® Àü½Å ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­ÇÏ´Â ´ëü °æ·Î¸¦ Á¦°øÇϹǷΠÀÚÁÖ »ç¿ëÇϰųª À̵¿ Áß¿¡µµ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

·Ñ¿ÂÀÇ Àαâ´Â ¼¿ÇÁ ÄÉ¾î ¹× Ãµ¿¬ À£ºù ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ±¤¹üÀ§ÇÑ º¯È­¿Í ÀÏÄ¡ÇÕ´Ï´Ù. ·Ñ¿ÂÀº ¼ºÀÎ, ¾î¸°ÀÌ, ³ëÀÎ, ƯÈ÷ ÀǾàǰ »ç¿ëÀ» Á¦ÇÑÇϰųª ÃÖ¼ÒÈ­ÇØ¾ß ÇÏ´Â °èÃþ¿¡¼­ ¼ºÀÎ, ¾î¸°ÀÌ, ³ë¾àÀÚ ¸ðµÎ¿¡°Ô ¾ÈÀüÇÏ´Ù´Â ÀÌÀ¯·Î ³Î¸® ÆÇ¸ÅµÇ°í ÀÖ½À´Ï´Ù. ¿©Çà, »ç¹«½Ç ±Ù¹«, Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏ Áõ°¡·Î ÀÎÇØ ÈÞ´ë°¡ °£ÆíÇÏ°í º¹¿ëÇϱ⠽¬¿î ·Ñ¿Â Á¦Ç°Àº ¹°À̳ª º¹¿ë¹ý ¾øÀ̵µ Áï°¢ÀûÀÎ È¿°ú¿Í Æí¾ÈÇÔÀ» ¿øÇÏ´Â ¼ÒºñÀÚµéÀÌ ¼±È£ÇÏ´Â °¨±â¾à ¼Ö·ç¼ÇÀÌ µÇ°í ÀÖ½À´Ï´Ù.

Á¦Çü µ¿Çâ°ú Á¦Ç° Çõ½ÅÀº ÄÝµå ¸±¸®ÇÁ ·Ñ¿Â ½ÃÀåÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

Á¦Ç° Çõ½ÅÀº °¨±â¾à ·Ñ¿ÂÀÇ ÁøÈ­¸¦ °áÁ¤Áþ´Â ¿ä¼ÒÀÔ´Ï´Ù. °¢ Á¦Á¶¾÷üµéÀº ¾Æ±â¿¡°Ô ¾ÈÀüÇÑ À¯Çü, ¼ºÀÎÀ» À§ÇÑ ÃæÇ÷Á¦°ÅÁ¦¸¦ ´õ ¸¹ÀÌ ÇÔÀ¯ÇÑ Ã³¹æ, ¹Î°¨ÇÑ »ç¿ëÀÚ¸¦ À§ÇÑ Ãµ¿¬ ¼ººÐ ÇÔÀ¯ µî ƯÁ¤ °èÃþ¿¡ ¸Â´Â ¹èÇÕÀ» Çϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ººÐÀ¸·Î´Â ÄÚ¸·ÈûÀ» ÇØ¼ÒÇÏ´Â À¯Ä®¸³Åõ½º ¿ÀÀÏ, Ä𸵠ȿ°ú°¡ ÀÖ´Â ¸àÅç, ÅëÁõÀ» ¿ÏÈ­Çϴ įÆÄ¸£, ÁøÁ¤ È¿°ú¸¦ ³ôÀÌ´Â ¶óº¥´õ¿Í ·ÎÁ¸® µîÀÌ ÀÖ½À´Ï´Ù. ÃÖ±Ù¿¡´Â ÁøÅë, Ç׿°, Ç×±Õ ÀÛ¿ëÀ» ÇϳªÀÇ Á¦Ç°¿¡ ¹èÇÕÇÏ¿© ¿©·¯ Áõ»óÀ» ¿ÏÈ­ÇÏ´Â °í¼º´É¼º ·Ñ¿Âµµ ÀÖ½À´Ï´Ù.

ÆÐŰÁöÀÇ Çõ½ÅÀ¸·Î »ç¿ë ÆíÀǼº°ú ¸Å·Âµµ Çâ»óµÇ¾ú½À´Ï´Ù. ´©Ãâ ¹æÁö ¹× ¹Ì²ô·³ ¹æÁö ·Ñ·¯º¼ ¾îÇø®ÄÉÀÌÅÍ(Á¾Á¾ ³Ã°¢°¨À» À§ÇØ ±Ý¼Ó ÆÁÀ¸·Î µðÀÚÀÎµÈ °æ¿ì°¡ ¸¹À½)´Â ÀÌÁ¦ Ç¥ÁØÀ¸·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ºê·£µåµéÀÇ Áö¼Ó°¡´É¼º ¸ñÇ¥¿¡ µû¶ó ÄÄÆÑÆ®ÇÑ Æ©ºê¿Í ģȯ°æ ÆÐŰÁö°¡ ´õ¿í º¸ÆíÈ­µÇ¾î °¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾î¸°ÀÌ ¾ÈÀü ĸ, ¹«Ç⠿ɼÇ, ÇǺΰú Å×½ºÆ®¸¦ °ÅÄ£ Á¦Ç° µîÀº Á¦Ç° ¾ÈÀü°ú ¾Ë·¹¸£°Õ ¹Î°¨¼º¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀ» ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù. ÀϺΠ·Ñ¿Â Á¦Ç°µéÀº º¸´Ù ±¤¹üÀ§ÇÑ ¾Æ·Î¸¶Å×¶óÇÇ Æ÷Æ®Æú¸®¿À¿¡ Æ÷ÇԵǸç, Ȧ¸®½ºÆ½ Çコ&À£´Ï½º Ä«Å×°í¸® ³»¿¡¼­ÀÇ ¿¬°ü¼ºÀÌ ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù.

°¨±â¾à ·Ñ¿ÂÀÇ ¼ºÀåÀ» ÁÖµµÇÏ´Â ¼ÒºñÀÚ ºÎ¹®°ú Áö¿ª ½ÃÀåÀº?

°¨±â¾à ·Ñ¿Â¿¡ ´ëÇÑ ¼ö¿ä´Â ÀÏ»óÀûÀÎ Áúº´¿¡ ´ëÇÑ ½Å¼ÓÇÏ°í ¾à¹°À» »ç¿ëÇÏÁö ¾Ê´Â ÇØ°áÃ¥À» ã´Â °Ç°­ ÁöÇâÀûÀÎ ¼ÒºñÀÚÃþ¿¡ ÀÇÇØ Áö¿øµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ¼Ò¾Æ °¨±â¾àÀÌ ¾ö°ÝÇÏ°Ô ±ÔÁ¦µÇ°Å³ª »ç¿ëÀ» ÀÚÁ¦ÇÏ´Â Áö¿ª¿¡¼­´Â ¾î¸° Àڳฦ µÐ ºÎ¸ðµéÀÌ ÁÖ °í°´ÃþÀÔ´Ï´Ù. ¶ÇÇÑ Á÷ÀåÀΰú ¿©ÇàÀÌ ÀæÀº »ç¶÷µéÀº ±× ½ÅÁßÇÔ°ú »ç¿ë ÆíÀǼº ¶§¹®¿¡ ·Ñ¿ÂÀ» ¼±È£ÇÕ´Ï´Ù. °í·ÉÀÇ ¼ÒºñÀڵ鿡°Ô ·Ñ¿ÂÀº ºñħ½ÀÀû Àü´Þ°ú ¾à¹°»óÈ£ÀÛ¿ëÀÇ À§Çè °¨¼Ò(ƯÈ÷ ´Ù¸¥ ¾à¹°°ú º´¿ëÇÒ ¶§)·Î Æò°¡¹Þ°í ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ¿¡¼¾¼È ¿ÀÀÏ, Çãºê ¿ä¹ý, ¿Ü¿ë¹ã¿¡ ´ëÇÑ ¹®È­Àû Ä£¹Ð°¨ÀÌ ¿øµ¿·ÂÀÌ µÇ¾î ¸àÅç Á¦Ç° äÅÃÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. Àεµ, Áß±¹, ű¹, Àεµ³×½Ã¾Æ¿Í °°Àº ±¹°¡¿¡¼­´Â È£Èí±â ÁúȯÀ» ¿ÏÈ­Çϱâ À§ÇØ ¸àÅçÀÌ ÇÔÀ¯µÈ Á¦Ç°À» »ç¿ëÇÏ´Â ÀüÅëÀÌ ¿À·¡ÀüºÎÅÍ ÀÖ¾ú½À´Ï´Ù. ºÏ¹Ì¿Í À¯·´¿¡¼­´Â ƯÈ÷ ÀÚ¿¬ ¿ä¹ý ¹× OTC ¼¿ÇÁ ÄÉ¾î ºÐ¾ß¿¡¼­ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿¿¡¼­´Â ºñ°æ±¸Àû Áõ»ó ¿ÏÈ­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ¾à±¹ ¹× ¿Â¶óÀÎ Ç÷§ÆûÀ» ÅëÇÑ ¼Ò¸Å Á¢±Ù¼ºÀÌ °³¼±µÊ¿¡ µû¶ó ·Ñ¿Â ½ÃÀå Á¡À¯À²ÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

ÄÝµå ¸±¸®ÇÁ ·Ñ¿Â ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

ÄÝµå ¸±¸®ÇÁ ·Ñ¿Â ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­, ½Ä¹°¼º °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, OTC À£´Ï½º Á¦Ç° Áõ°¡ÀÔ´Ï´Ù. Áß¿äÇÑ ¿øµ¿·ÂÀº Çö´ëÀÎÀÇ À̵¿ÀÌ ÀæÀº ¶óÀÌÇÁ½ºÅ¸ÀÏ¿¡ ¸ÂÃß¾î Á¹À½À» À¯¹ßÇÏÁö ¾Ê°í Àü½Å¿¡ ÀÛ¿ëÇÏ´Â °¨±â¾à¿¡ ´ëÇÑ ¼ö¿äÀÔ´Ï´Ù. ¼ÒºñÀÚµéÀÌ Á¡Á¡ ´õ ´Ù±â´ÉÀûÀ̰í ÈÞ´ë °¡´ÉÇÑ ÇコÄÉ¾î ¼Ö·ç¼ÇÀ» ã°í ÀÖ´Â °¡¿îµ¥, ·Ñ¿ÂÀº »ç¿ëÀÇ ¿ëÀ̼º, ºü¸¥ È¿°ú, ºÎÀÛ¿ëÀÌ Àû´Ù´Â Á¡¿¡¼­ ´«¿¡ ¶ë´Ï´Ù.

¿¡¼¾¼È ¿ÀÀÏ Å×¶óÇÇ¿Í ¾Æ·Î¸¶Å×¶óÇÇ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÁÖ·ù ÇコÄÉ¾î »ç¿ëÀÚµé »çÀÌ¿¡¼­ ÀÚ¿¬ ¿ä¹ýÀÌ ¹Þ¾Æµé¿©Áö°í ÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ÈûÀ» ½Ç¾îÁÖ°í ÀÖ½À´Ï´Ù. ¸¶ÄÉÆÃ°ú À£´Ï½º ±â¹Ý ºê·£µùÀ» ÅëÇØ ¼¼°è ±Ô¸ð¸¦ È®´ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ È£Èí±â °Ç°­°ú ¸é¿ª·Â Çâ»ó¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ °¨±â¾à ·Ñ¿Â°ú °°Àº ¿¹¹æ ¹× Áõ»ó °ü¸® ÅøÀÇ Ã¤ÅÃÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

ó¹æ, µðÀÚÀÎ, À¯ÅëÀÇ Çõ½ÅÀ¸·Î °¨±â¾à ·Ñ¿ÂÀº ƯÈ÷ °¨±â, µ¶°¨, ¾Ë·¹¸£±â °ü¸® Ä«Å×°í¸®¿¡¼­ °³ÀÎ À£ºù ·çƾÀÇ ÇʼöÀûÀÎ ºÎºÐÀ¸·Î ÀÚ¸® ÀâÀ» Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

ºÎ¹®

¾ÖÇø®ÄÉÀ̼Ç(°¨±â/±âħ ¾ÖÇø®ÄÉÀ̼Ç, ÄÚ ¾Ë·¹¸£±â ¾ÖÇø®ÄÉÀ̼Ç, ÄÚ¸·Èû ¾ÖÇø®ÄÉÀ̼Ç, ±âŸ ¾ÖÇø®ÄÉÀ̼Ç), À¯Åë ä³Î(¼Ò¸Å ¾à±¹, º´¿ø ¾à±¹, ½´ÆÛ¸¶ÄÏ/ÇÏÀÌÆÛ¸¶ÄÏ, ¿Â¶óÀÎ À¯Åë ä³Î)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 47°Ç)

AI ÅëÇÕ

¿ì¸®´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å¿¡ ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cold Relief Roll-on Market to Reach US$856.7 Million by 2030

The global market for Cold Relief Roll-on estimated at US$544.5 Million in the year 2024, is expected to reach US$856.7 Million by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Cold / Cough Application, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$447.7 Million by the end of the analysis period. Growth in the Nasal Allergies Application segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$148.3 Million While China is Forecast to Grow at 12.6% CAGR

The Cold Relief Roll-on market in the U.S. is estimated at US$148.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$186.0 Million by the year 2030 trailing a CAGR of 12.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Global Cold Relief Roll-On Market - Key Trends & Drivers Summarized

Why Are Cold Relief Roll-Ons Becoming Increasingly Popular Among Consumers Seeking Fast-Acting Relief?

Cold relief roll-ons are gaining strong consumer traction due to their convenience, non-invasive application, and perceived natural efficacy in managing symptoms of the common cold, such as nasal congestion, headaches, and muscle soreness. These topical formulations typically combine essential oils such as eucalyptus, camphor, peppermint, and menthol, delivering symptomatic relief through aromatherapy and localized skin absorption. Unlike oral medications, roll-ons offer an alternative route that minimizes systemic side effects, making them suitable for frequent or on-the-go use.

Their growing popularity aligns with a broader consumer shift toward self-care and natural wellness solutions. Roll-ons are widely marketed as safe for adults, children, and even the elderly, especially in segments where pharmaceutical use may be restricted or minimized. The rise in travel, office-based work, and active lifestyles has made portable, easy-to-apply roll-on products a preferred cold relief solution for consumers who seek immediate comfort without needing water or dosage instructions.

How Are Formulation Trends and Product Innovation Shaping the Cold Relief Roll-On Market?

Product innovation is a defining factor in the evolution of cold relief roll-ons. Manufacturers are increasingly formulating blends that cater to specific demographics-such as baby-safe variants, decongestant-heavy formulations for adults, or all-natural blends for sensitive users. Key ingredients include eucalyptus oil for decongestion, menthol for a cooling effect, camphor for pain relief, and lavender or rosemary for added calming benefits. Some advanced roll-ons now feature multi-symptom relief by combining soothing, anti-inflammatory, and antimicrobial properties in a single product.

Packaging innovations have also enhanced usability and appeal. Leak-proof, glide-on rollerball applicators-often designed with metal tips for a cooling sensation-are now the standard. Compact tubes and eco-friendly packaging are becoming more prevalent as brands align with sustainability goals. Additionally, child-safe caps, fragrance-free options, and dermatologically tested variants reflect growing awareness around product safety and allergen sensitivity. Some roll-ons are also being positioned within broader aromatherapy portfolios, further reinforcing their relevance within the holistic health and wellness category.

Which Consumer Segments and Regional Markets Are Driving Growth in Cold Relief Roll-Ons?

Demand for cold relief roll-ons is being fueled by a wide base of health-conscious consumers looking for fast, drug-free solutions to everyday ailments. Parents with young children represent a core demographic, especially in regions where pediatric cold medications are tightly regulated or discouraged. Working professionals and frequent travelers also favor roll-ons for their discretion and ease of use. Among older consumers, roll-ons are valued for their non-invasive delivery and reduced risk of drug interactions-especially when used alongside other medications.

Regionally, Asia-Pacific leads in adoption, driven by cultural familiarity with essential oils, herbal remedies, and topical balms. Countries like India, China, Thailand, and Indonesia have long-standing traditions of using mentholated products for respiratory relief. North America and Europe are witnessing rising demand, particularly within the natural remedies and OTC self-care space. In Latin America and the Middle East, roll-ons are gaining market share as awareness around non-oral symptom relief grows and retail access improves through pharmacies and online platforms.

What Is Driving the Growth of the Cold Relief Roll-On Market?

The growth in the cold relief roll-on market is driven by the convergence of lifestyle changes, increasing preference for plant-based health solutions, and the growing availability of OTC wellness products. A significant driver is the demand for non-drowsy, non-systemic cold relief options that align with modern, mobile lifestyles. As consumers increasingly seek multi-functional and portable healthcare solutions, roll-ons stand out for their ease of use, rapid onset of action, and low side-effect profile.

Rising awareness of essential oil therapy and aromatherapy, along with growing acceptance of natural remedies among mainstream healthcare users, is also boosting market expansion. The role of e-commerce is pivotal, allowing niche and regional brands to scale globally through targeted marketing and wellness-based branding. Moreover, the COVID-19 pandemic has increased consumer focus on respiratory health and immune-boosting practices, further accelerating adoption of preventive and symptom management tools like cold relief roll-ons.

As innovation continues across formulation, design, and distribution, cold relief roll-ons are poised to become an integral part of personal wellness routines, particularly in the cold, flu, and allergy management categories.

SCOPE OF STUDY:

The report analyzes the Cold Relief Roll-on market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Cold / Cough Application, Nasal Allergies Application, Nasal Congestion Application, Other Applications); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Supermarkets / Hypermarkets, Online Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â